Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ann Hematol ; 97(12): 2333-2343, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30109425

RESUMO

In patients suspected to have myelodysplastic syndrome (MDS), especially in those patients without cytogenetic abnormalities or blast excess, accurate morphologic review by an expert hematopathologist and meticulous exclusion of other secondary causes of myelodysplasia are vital to establish the diagnosis. Errors in diagnosis can lead to dangerous consequences such as the administration of hypomethylating agents, lenalidomide, or even the use of intensive chemotherapy or allogeneic hematopoietic cell transplantation in patients who do not have an underlying MDS or even a malignant hematopoietic process. Additionally, beyond the possible harm and lack of efficacy of such therapies if the diagnosis of MDS is erroneous, the secondary myelodysplasia and resultant cytopenias are not likely to resolve unless the underlying etiology is identified and addressed. Discriminating a malignant process such as MDS from non-malignant secondary myelodysplasia can be quite challenging, and community hematologists/oncologists should consider referral to specialized physicians (both clinical experts and experienced hematopathologists) if there is any doubt regarding the diagnosis. In this article, we present a representative case series of patients from our own practice who posed diagnostic dilemmas and propose a systematic approach for assessment for secondary causes of myelodysplasia.


Assuntos
Neoplasias Hematológicas/diagnóstico , Síndromes Mielodisplásicas/diagnóstico , Adulto , Diagnóstico Diferencial , Feminino , Neoplasias Hematológicas/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Síndromes Mielodisplásicas/terapia
2.
Am J Case Rep ; 18: 669-673, 2017 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-28615616

RESUMO

BACKGROUND Mucinous ovarian adenocarcinoma is one of the less common epithelial cancers of the ovaries, and typically does not occur in younger women. Nearly all mucinous ovarian adenocarcinomas present with early-stage disease without significant sequelae of cancer, such as clotting. Anchoring bias is a common problem in medicine that has been shown to significantly affect physician decision-making. CASE REPORT We present the case of a 24-year-old healthy female Chinese immigrant with no significant past medical history, who presented with a subacute history of nonproductive cough and shortness of breath with exertion. Initial workup was directed towards diagnosis of tuberculosis and other infectious etiologies due to anchoring to patient's nationality and her positive family history for tuberculosis. She was eventually diagnosed with extensive bilateral pulmonary emboli and bilateral deep vein thromboses as well as a right ventricular thrombus. This extensive clot burden helped lead to the diagnosis of mucinous ovarian adenocarcinoma. CONCLUSIONS This case is significant not only because the diagnosis of mucinous ovarian adenocarcinoma is uncommon in healthy young females under the age of 25, but, more importantly, because such extensive pulmonary emboli and deep vein thromboses in a young female with local/early-stage ovarian cancer is very rare. This case is also significant because it serves as an important reminder of the risks of anchoring bias in skewing perceptions and delaying the correct diagnosis by physicians.


Assuntos
Adenocarcinoma Mucinoso/patologia , Ventrículos do Coração , Neoplasias Ovarianas/patologia , Embolia Pulmonar/etiologia , Trombose/etiologia , Trombose Venosa/etiologia , Tosse/etiologia , Erros de Diagnóstico , Dispneia/etiologia , Feminino , Humanos , Derrame Pleural Maligno/etiologia , Embolia Pulmonar/diagnóstico por imagem , Trombose/diagnóstico por imagem , Adulto Jovem
3.
Am J Case Rep ; 17: 977-981, 2016 Dec 23.
Artigo em Inglês | MEDLINE | ID: mdl-28008165

RESUMO

BACKGROUND Tuberculous meningitis is very rare in the United States in immunocompetent hosts. Risk factors are similar to those of pulmonary tuberculosis, including poverty, malnutrition, overcrowding, a compromised immune system, and coming from an endemic area. Meningeal tuberculosis mortality and other outcomes have changed little over time despite effective therapies due to delay in diagnosis because of its rarity, variable presentation, and often indolent course. CASE REPORT We describe a case of a 57-year-old male immigrant from Senegal with no significant past medical history and no previous history of tuberculosis or evidence of immune compromise. He presented to the hospital with headache and altered mental status and was subsequently diagnosed with tuberculous meningitis. CONCLUSIONS This is a rare case of tuberculous meningitis in an immunocompetent host, questioning the conventional view that tuberculous meningitis is a disease of immunocompromised individuals. It emphasizes the importance of maintaining a strong clinical suspicion of tuberculous meningitis even in an immunocompetent patient in a geographical area with low prevalence if the patient has risk factors. Missed or delayed diagnosis is commonly fatal.


Assuntos
Imunocompetência , Mycobacterium tuberculosis/imunologia , Tuberculose Meníngea/diagnóstico , Antituberculosos/uso terapêutico , Líquido Cefalorraquidiano/imunologia , Quimioterapia Combinada , Emigrantes e Imigrantes , Humanos , Isoniazida/uso terapêutico , Levofloxacino/uso terapêutico , Masculino , Pessoa de Meia-Idade , Pirazinamida/uso terapêutico , Rifampina/uso terapêutico , Senegal , Resultado do Tratamento , Tuberculose Meníngea/tratamento farmacológico , Tuberculose Meníngea/imunologia , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA